Virginie Busignies

Virginie Busignies

Auto-generated profile, based on publicly available information

Virginie Busignies

Univ. Bordeaux, CNRS, Arts et Metiers Institute of Technology, Bordeaux INP, INRAE I2M, Bordeaux F-33400, Talence, France

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2010 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
FMF. Michaut
F. Michaut
VBV. Busignies
V. Busignies
CFC. Fouquereau
C. Fouquereau
BBB. Huet de Barochez
B. Huet de Barochez
BLB. Leclerc
B. Leclerc
PTP. Tchoreloff
P. Tchoreloff

1 November 2013 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
VBVirginie Busignies
Virginie Busignies
VMVincent Mazel
Vincent Mazel
HDHarona Diarra
Harona Diarra
PTPierre Tchoreloff
Pierre Tchoreloff

1 October 2012 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
VBV. Busignies
V. Busignies
VMV. Mazel
V. Mazel
HDH. Diarra
H. Diarra
PTP. Tchoreloff
P. Tchoreloff

8 July 2010 in Drug Development and Industrial Pharmacy
Verified
Journal Article
Closed access
PDF file
VBVirginie Busignies
Virginie Busignies
BLBernard Leclerc
Bernard Leclerc
STStéphane Truchon
Stéphane Truchon
PTPierre Tchoreloff
Pierre Tchoreloff
Objective: The aim of this work is to study the effect of compaction on the specific surface area of tablets composed of various pharmaceutical materials (microcrystalline cellulose, lactose, and anhydrous calcium phosphate) compacted under seven degrees of compaction pressure. Methods: In a first part, the influence of the deformation behavior of the compacted materials on the evolution of the specific surface area is observed. In a second part, the brittle and ductile abilities of the materials are calculated using the specific surface area values. The experimental results are used to calculate the number and the force of interparticulate bonds inside the tablet.Results and Discussion: Tablets made of microcrystalline cellulose, which deform plastically, have specific surface areas that fall under pressure. In the case of lactose, the tablet specific surface area first increases to reach a maximum value at a pressure of 150 MPa. At higher pressure, however, the specific surface area decreases. The specific surface area of tablets composed of anhydrous calcium phosphate consistently increases, whatever the compaction pressure applied. Moreover, the evolution of the specific surface area is correlated with the tensile strength of the corresponding tablets. The number and the force of interparticulate bonds make it possible to classify the materials according to their deformation behavior and to quantify their ability to form cohesive tablets.

3 March 2020 in Molecular Pharmaceutics
Verified
Journal Article
Open access
VBVirginie Busignies
Virginie Busignies
DADanielle Campiol Arruda
Danielle Campiol Arruda
CCChristine Charrueau
Christine Charrueau
MRMarcela Ribeiro
Marcela Ribeiro
ALAnne-Marie Lachagès
Anne-Marie Lachagès
VEVirginie Escriou
Virginie Escriou
Currently, most non-viral nucleic acid vectors are in the form of colloidal suspensions administered primarily parenterally. This type of formulation and the mode of administration impose strong constraints such as the size of the administered vectors or the production of sterile preparations. The tablet form provides access to easy oral administration, well accepted by patients, it is also an advance for the stability of the nucleic acids vectors, since it is a dry form. Using an optimized lipid-based small interfering RNA delivery system, we studied the tabletability of a liquid suspension of these vector. We optimized the conditions of freeze-drying by choosing excipients and process, allowing for the conservation of both the gene silencing efficacy of the formulated siRNAs and the supramolecular structure of the lipid particulate system. Gene silencing efficacy was assayed on luciferase-expressing cells and the structure of the siRNA vector in freeze-dried and tablet forms was examined using SAXS Synchrotron radiation. The freeze-dried powders were then mixed with excipients necessary for the good progress of the compression by allowing for a regular supply of the matrix and the reduction of friction. The compression was carried out using a rotary press simulator that allow for complete monitoring of the compression conditions. After compression, formulated siRNAs retained more than 60% of their gene silencing efficacy. Within the tablets, a specific SAXS signal was detectable and the lamellar and cubic phases of the initial liquid suspension were restored after re-suspension of siRNA vectors by disintegration of the tablets. These results show that the bilayer lipid structures of the particles were preserved despite the mechanical constraints imposed by the compression. If such a result could be expected after the freeze-drying step, it was never shown, to our knowledge, that siRNA delivery systems could retain their efficacy and structure after mechanical stress such as compression. This opens promising perspectives to oral administration of siRNA as an alternative to parenteral administration.

1 December 2014 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
VBVirginie Busignies
Virginie Busignies
VMVincent Mazel
Vincent Mazel
HDHarona Diarra
Harona Diarra
PTPierre Tchoreloff
Pierre Tchoreloff